Claude Bertrand
Director/Board Member at MAAT PHARMA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Olivier Laureau | M | 67 |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | 42 years |
Catherine Mazzacco | F | 59 |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Hervé Affagard | M | - | 10 years | |
Bernard Le Pezron | M | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Jean Volatier | M | 59 | 3 years | |
Matthias Staehelin | M | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Karim Dabbagh | M | - | 1 years | |
Dorothée Burkel | F | 61 | 3 years | |
Jean-Marie Lefèvre | M | - | 8 years | |
Nadia Kamal | M | - | 1 years | |
Gijs Melching | M | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Karin Garre | M | 67 |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | 6 years |
Christian Wyss | M | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Siham Imani | F | 47 |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | 13 years |
Christophe Thurieau | M | - |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | 4 years |
Siân Crouzet | F | - | 8 years | |
Aymeric Le Chatelier | M | 55 | 10 years | |
Michèle Ollier | M | 65 | 9 years | |
Marc M. P. de Garidel | M | 66 | 14 years | |
Jean-Christophe Tellier | M | 65 |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Kapil Dhingra | M | 64 |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | 2 years |
Carole Schwintner | M | - | 10 years | |
Pascal Lemaire | M | - |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | - |
Guilhaume Debroas | M | - | 1 years | |
Philippe Moyen | M | - | 1 years | |
Nathalie Corvaïa | M | - | 2 years | |
Fernand Bertrand | M | - |
Bertrand Vigouroux SA
Bertrand Vigouroux SA Home Improvement ChainsRetail Trade Bertrand Vigouroux SA retails and wholesales garden products. The company is headquartered in Grasse, France. | - |
Gervais Tougas | M | 67 | 1 years | |
Emilie Plantamura | M | - | 2 years | |
Benoît Habert | M | 59 |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | - |
Benoit Chéron | M | - |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | - |
Patricia Lafaix-Houser | F | - |
Servier IP UK Ltd.
Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a private company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | - |
Jean Zetlaoui | M | - |
Alliance for Research & Innovation in Health Industries
| - |
Pierre Dussaud | M | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
Isabelle de Cremoux | F | 54 | 10 years | |
François-Maurice Garnier | M | 62 | 9 years | |
Karine Gaudin | F | 58 | 2 years | |
Muriel Prudent | F | - | - | |
Jesús Martin-Garcia | M | 62 |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | - |
Nicolas Charles Bouts | M | 65 |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | 39 years |
Carol Xueref | F | 67 | 12 years | |
Annick Schwebig | M | 73 |
Alliance for Research & Innovation in Health Industries
| - |
Ange Diaz | M | 78 |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | - |
William Vickery | M | 57 |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sonia Benhamida | M | - | 7 years | |
Martha Heitzmann-Crawford | M | 56 | 3 years | |
Jean-Luc Bélingard | M | 74 | 8 years | |
Christian Schubert | M | - |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | 3 years |
David Meek | M | 59 | 3 years | |
Claire Giraut | F | 67 | 8 years | |
Martine George | M | 76 | 1 years | |
David S. Schilansky | M | 48 | 5 years | |
Hélène Auriol-Potier | F | 61 | 4 years | |
Pierre Kemula | M | 50 | 6 years | |
Dominique Laymand | F | 69 | - | |
Thomas Gidoin | M | 41 | 3 years | |
Philippe Robert-Gorsse | M | 63 | 11 years | |
Eugenia Litz | F | - | - | |
Béatrice Bihr | F | - |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | 2 years |
Heather White | F | - | - | |
Sotirios G. Stergiopoulos | M | 52 | 2 years | |
Christopher Cozic | M | 46 | 3 years | |
Isabelle Adeline | M | - | 3 years | |
Eugenio Fernandez | M | - | 2 years | |
Christy Oi | F | - | 4 years | |
Jonathan Henry Barnsley | M | 67 | - | |
Andrew Grethlein | M | 59 | 2 years | |
Dominique Brard | F | 61 | - | |
Stéphane Durant des Aulnois | M | - | - | |
Richard B. Love | M | 62 | 4 years | |
Nathalie Joannes | F | - | 4 years | |
John D. Weinberg | M | 57 | 2 years | |
Stéphane Bessette | M | 58 | - | |
Susheel Surpal | M | - | 3 years | |
Klaus-Peter Schwabe | M | 82 | - | |
Alexandre LeBeaut | M | 66 | 6 years | |
Jérôme Féraud | M | 49 | - | |
Chidozie Ugwumba | M | 41 | 1 years | |
Didier Véron | M | - | 5 years | |
Christel Bories | F | 60 | 3 years | |
Gérard Hauser | M | 81 | 9 years | |
Christophe Vérot | M | 63 | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 75 | 91.46% |
Denmark | 4 | 4.88% |
Switzerland | 2 | 2.44% |
United Kingdom | 1 | 1.22% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Claude Bertrand
- Personal Network